L2 - Molecular Basis Of Disease Flashcards

(44 cards)

1
Q

Explain disease at molecular level

A

Change at DNA, RNA, and protein level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What leads to changes in the protein quality, quantity, and function

A

Mutation of genes and changes during transcription,translation, and post translation level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Disease at gross or microscopic level

A

Morphology and biochemical alterations in body fluids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Genetic changes in germ cells

A

Transmitted to progeny
Lead to inherited diseases (hereditary disorders)
Familial/ congenital

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Genetic changes in somatic cells

A

Not transmitted to progeny
Still responsible for disease cause
Not familial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mutation in DNA

A

Permanent change in DNA sequence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Chromosomal alteration

DELETION

A

Loss of chromosomal fragment - gene loss or deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Chromosomal alteration

DUPLICATION

A

Fusion of proteins or amplification of genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Chromosomal alteration

INVERSION

A

Segment of chromosome reversed end by end

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chromosomal alteration

TRANSLOCATION

A

Exchange two chromosome segments = fusion of proteins + altered gene expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Aneuploidy

A

Whole chromosome gains or loses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Epigenetic changes

A

Modulation of gene/ protein expression in absence of alteration in DNA sequence or structure

  • DNA methylation
  • histone modification
  • non coding RNAs
  • protein modification
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DNA methylation of cytosine @ gene promoters

A

Promoters become inaccessible to RNA polymerase = transcriptional silencing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Histone modifications

A

Methylation and acetylation of secondary and tertiary DNA structure + regulate gene transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Non coding RNAs - miRNA and IncRNA

A

miRNA - doesn’t encode proteins but inhibit translation of target mRNAs into corresponding proteins
IncRNA - binding to chromatin and modulate gene expression, restrict access of RNA polymerase to coding genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Protein modification

A

Folding and phosphorylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Sickle cell disease molecular pathogenesis

A

Normal( CTC ) in the beta-globn chain changes to ( CAC ) and change of (glutamine) to (valine)

Beta-globin chain -> sickle beta-globin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What type of mutation is SCD

A

Point mutation

Valine for glutamine @ 6th amino acid = structurally abnormal molecule ( hemoglobin S)

19
Q

What happens when hg S is polymerized?

A

Cytoplasm become rigid filamentous gel and leads to less deformable sickles erythrocytes

20
Q

What does the rigidity of sickles erythrocytes lead to?

A
  • obstruction of the microcirculation, tissue hypoxia and ischemic injury in many organs
  • because sickle cells are inflexible this leads to hemolysis in spleen during circulation
21
Q

What are the two primary manifestations of sickle cell diseas

A

recurrent ischemic events and hemolytic anemia

22
Q

SCD clinical manifestations

A
Retinopathy- blindness
Stroke
Pneumonia -lung infarcts- acute chest syndrome 
Iron overload in heart and liver 
Spleen atrophy 
Osteomyelitis 
Skin ulcers 
Kidney lower ability
23
Q

Molecular pathogenesis of chronic myeloid leukemia (CML)

A

BCR-ABL fusion gene by translocation =(Philadelphia chromosome)
The fusion makes signals that mimic effect of growth factor activation =CML cells grow and reproduce
(Gene 9 and 22)

24
Q

Diagnosis of CML

A

Using translocation bcz its available in most CML patients

25
Treatment of CML
Tyrosine kinase inhibitor (Imatinib)
26
Signal pathways of BCR-ABL
Transforming hematopoietic cells to cancer cells
27
Acute promyelocytic leukemia molecular pathogenesis
translocation between chromosomes 15 and 17 = fusion of PML and RARa gene PML/RARa = blocking myeloid differentiation at promyelocytic stage
28
APL treatment
all-trans retinoic acid (ATRA) survival higher than cytotoxic therapy - Mechanism: binds to PML\RARa causes neoplastic promyelocytes to rapidly differentiate into neutrophils bcz neutrophils die after 6hrs= clearing the tumor (If AML doesn’t have RARa translocation it wont respond to ATRA)
29
Cystic fibrosis cause
mutations of the CF transmembrane Conductance Regulator (CFTR) gene
30
What is the CFTR
anion channel that regulates the transmembrane ion transport
31
Mutation in CFTR
= defective electrolyte transport (chloride ion) in epithelial cells which affects salt absorption, fluid absorption ,and anion-mediated fluid secretion -complex multi system disease
32
Pathogenesis of respiratory and intestinal complications in CF
Low-volume of surface fluid layer -> dehydration in lungs ->accumulation of secretions -> obstruction of air passage and pulmonary infections ( cause of mortality in CF)
33
CFTR defect in sweat duct
High chloride and sodium concentration in sweat
34
CFTR defect in lung
- Low chlorine and high sodium and water reabsorption= dehydration of mucus layer and defect in mucociliary action - mucous plugging and tracheobrachial dilation - greenish discoloration bcz of bacterial infection
35
diabetes mellitus cause
insulin resistance and beta cell dysfunction = insulin deficiency (doesn’t involve autoimmunity)
36
Insulin resistance
Failure of tissue to respond normally to insulin caused by reduction in phosphorylation dependent activation of the insulin receptor and its components = signal transduction
37
Lack of insulin
=catabolic state effects glucose fat and protein metabolism | -bad glucose storage= hyperglycemia
38
Hyperglycemia = ?
-activation of the mitogen activated protein kinase (MAPK) pathway and oxidative stress=clinical presentations
39
Genetics and DM
Diabetogenic | Obesity related genes
40
Environmental influences and DM
Obesity | Sedentary life style
41
How does obesity lead to insulin resistance
Adipose tissues release cytokines and FFAs affect activity of key insulin signaling proteins -FFAs= beta cell dysfunction and release of pro inflammatory cytokines
42
Viruses - mechanism of disease (3 ways)
1. Direct cytopathy-> virus kills cell by stopping synthesis of macromolecules, producing toxins, and apoptosis 2. Antiviral immune response inflammation =tissue damage 3. Transform infected cells to tumor cells
43
Cancer
Multiple gene abnormalities
44
Breast cancer biomarkers
1. Estrogen receptor in breast carcinoma (good prognosis) - Tamoxifen targets estrogen receptor and blocks it 2. HER-2 in breast carcinoma (worse prognosis) - herceptin blocks HER-2 growth signals